Treatment of Viral Pneumonia Flashcards
How can you differentiate between viral and bacterial causes of pneumonia on the basis of: • Age • Epidemic Situation • History of Illness • Clinical Profile
Age:
• younger than 5 - viral
• Adults - bacterial
Epidemic Situation:
• Ongoing viral epidemic
• Bacterial things usually aren’t epidemic
History of Illness:
• Slow onset - viral
• Rapid onset - bacterial
Clinical profile:
• Rhinitis, wheezing
• High fever, tachypnea
What parameters suggest either viral or bacterial etiology for each of the following biomarkers?
• WBC.
• C-reactive protein concentration in serum
• Pro-calcitonin concentrations in serum
• Chest Radiograph
• Respsonse to antibiotic Tx.
WBC:
Viral - less than 10 x 10^9
Bacterial - more than than 15 x 10^9
C-reactive Protein concentration:
Viral - less than 20 mg/L
Bacterial - more than 60 mg/L
Pro-calcitonin concentration in serum:
Viral - less than 0.1 µg/L
Bacterial - more than 0.5 µg/L
Chest radiograph:
Viral - bilateral and intersitial
Bacterial - lobar
Response to Abx:
Viral - non-responsive
Bacterial - rapid
What treatment and prevention methods do we have for Influenza A and B?
• MOA
• Metabolism
• Adverse Effects
Treatment:
Flu A ONLY:
• Amantadine (PO)
• Rimantadine (PO)
Flu A and B:
• Oseltamivir (PO)
• Zanamivir (inhalation)
Prevention:
• Vaccines - FLU A
• Oseltamivire, Zanamivir
MOA:
Amantadine/Rimantadine:
Inhibits the M2 ion channel preventing viral entry
Oseltamivir/Zanamivir:
Neuraminidase inhibitors that prevent release of the virus from the cell
Metabolism:
Amanatadine - no change in elimination by glomerular filtration and tubular secretion
Rimantadine - EXTENSTIVE HEPATIC metabolism with RENAL elimination of METABOLITES
Oseltamavir - Hepatically metabolized to the carboxylate active form of the drug, SYSTEMIC elimination by glomerular filtration and secretion
Zanamivir - Renally eliminated unchanged
Adverse Effects:
Amantadine - Nausea and orthostatic HTN, CONTRAINDICATED IN OPEN ANGLE GLAUCOMA and BREASTFEEDING
Rimantadine - minimal adverse effects
Oseltamavir - MINIMAL adverse effects - potential for fatal neuropsychiatric adverse effects in flu patients; serious skin reaction
Zanamivir - Headache, throat/tonsil pain, cough, viral infection, NOT to be used with underlying pulmonary disease - fatal bronchospasm
What methods of treatment and prevention do we have for RSV?
• MOA
• Metabolism
• Adverse Effects
Treatment:
• Ribavirin
Prevention:
• Palivizumab - (against adhesion protein F)
MOA:
• Ribaviron - Inhibition of viral nucleic acid synthesis
Metabolism:
• Ribaviron - non-CYP metabolism in nucleated cells with systemic elimination of drug and products in the urine
Adverse effects:
• Ribaviron - fatigue, headache, myalgia, nausea, fever BBW OF HEMOLYTIC ANEMIA and M/F TETROGENICITY
What methods of treatment and prevention do we have for Adenovirus?
• MOA
• Metabolism
• Adverse Effects
Treatment:
• Cidofovir (IV)
Prevention:
• Vaccine against types 4 and 7
MOA:
• Cidofovir - inhibition of viral DNA synthesis (DNA pols. inhibition)
Metabolism:
Cidofovir
• Metabolized via pyrimidine nucleosie monophosphate kinase to mono- and then diphosphate analogs and finally to the monophosphate-choline.
• SYSTEMICALLY eliminated by glomerular filtration and tubular secretion
Adverse effects:
• Cidofovir - Neurologic, hematologic, and tubular damage BBW OF RENAL IMPAIRMENT/TOXICITY
What methods of treatment and prevention do we have for Rhinovirus?
• MOA
• Metabolism
• Adverse Effects
Treatment:
• none
Prevention:
• Alfa Interferon (intranasal)
• Ribavirin (off-label)
MOA:
• Ribaviron - Inhibition of viral nucleic acid synthesis
Metabolism:
• Ribaviron - non-CYP metabolism in nucleated cells with systemic elimination of drug and products in the urine
Adverse effects:
• Ribaviron - fatigue, headache, myalgia, nausea, fever BBW OF HEMOLYTIC ANEMIA and M/F TETROGENICITY
What method of treatment and prevention do we have for Human metapeumovirus?
• MOA
• Metabolism
• Adverse Effects
Treatment:
• Ribaviron
Prevention:
• None
MOA:
• Ribaviron - Inhibition of viral nucleic acid synthesis
Metabolism:
• Ribaviron - non-CYP metabolism in nucleated cells with systemic elimination of drug and products in the urine
Adverse effects:
• Ribaviron - fatigue, headache, myalgia, nausea, fever BBW OF HEMOLYTIC ANEMIA and M/F TETROGENICITY
What method of treatment and prevention do we have for Hantavirus?
• MOA
• Metabolism
• Adverse Effects
Treatment:
•Ribaviron
Prevention:
• None
MOA:
• Ribaviron - Inhibition of viral nucleic acid synthesis
Metabolism:
• Ribaviron - non-CYP metabolism in nucleated cells with systemic elimination of drug and products in the urine
Adverse effects:
• Ribaviron - fatigue, headache, myalgia, nausea, fever BBW OF HEMOLYTIC ANEMIA and M/F TETROGENICITY
What method of treatment and prevention do we have for Varicella-zoster virus?
• MOA
• Metabolism
• Adverse Effects
Treatment:
• Acyclovir (IV)
• Valacyclovir (PO)
Prevention:
• Vaccine
MOA:
• Acyclovir - Inhibition of viral DNA synthesis (DNA pols. inhibition)
• Valacyclovir - pro-drug for acyclovir
Metabolism:
• Acyclovir - Infected cells change it to its active triphosphate form. SYSTEMIC elminated unchanged in the kidney
• Valacyclovir - Coverted to acyclovir (and L-valine) by 1st-pass metabolism. Systemic elimination of acyclovir is done by glomerular filtration
Adverse effects:
• Acyclovir - Headache, nausea, neurotoxicity (confusion, seizures) MUST hydrate to PREVENT RENAL precipitation. USE CAUTIOUSLY in renal impairment
• Valacyclovir - same as above + THROMBOCYTOPENIA
Rimantadine
MOA
Metabolism
Adverse Effects
MOA
Rimantadine - EXTENSTIVE HEPATIC metabolism with RENAL elimination of METABOLITES
Metabolism
Rimantadine - EXTENSTIVE HEPATIC metabolism with RENAL elimination of METABOLITES
Adverse Effects
Rimantadine - minimal adverse effects
Amantadine
MOA
Metabolism
Adverse Effects
MOA
Amantadine/Rimantadine:
Inhibits the M2 ion channel preventing viral entry
Metabolism
Amanatadine - no change in elimination by glomerular filtration and tubular secretion
Adverse Effects
Amantadine - Nausea and orthostatic HTN, CONTRAINDICATED IN OPEN ANGLE GLAUCOMA and BREASTFEEDING
Oseltamavir
MOA
Metabolism
Adverse Effects
MOA
Oseltamivir/Zanamivir:
Neuraminidase inhibitors that prevent release of the virus from the cell
Metabolism
Oseltamavir - Hepatically metabolized to the carboxylate active form of the drug, SYSTEMIC elimination by glomerular filtration and secretion
Adverse Effects
Oseltamavir - MINIMAL adverse effects - potential for fatal neuropsychiatric adverse effects in flu patients; serious skin reaction
Zanamavir
MOA
Metabolism
Adverse Effects
MOA
Oseltamivir/Zanamivir:
Neuraminidase inhibitors that prevent release of the virus from the cell
Metabolism
Zanamivir - Renally eliminated unchanged
Adverse Effects
Zanamivir - Headache, throat/tonsil pain, cough, viral infection, NOT to be used with underlying pulmonary disease - fatal bronchospasm